I n the face of disaster and suffering, there is a natural human impulse to reach out and help those in need. Medicines are an essential element in alleviating suffering in the sick. Having the appropriate drugs at the right time to treat the sick or injured people in disaster-or war-stricken and distressed regions of the world is an important component of the relief effort mounted to help the needy. Many international organizations usually respond with drug donations to help meet this emergency. Sometimes the quality of donated drugs does not comply with standards in the donor country. As discussed later, the donated drugs may have expired before they reach the patient. The expiry date of a drug product is determined according to the capability of a particular formulation in a specific container to remain within its physical, chemical, microbiologic, therapeutic, and toxicologic specifications for the period concerned. 1 The generally accepted limit of chemical activity throughout the shelf life of a medication requires at least 90% of the original potency. Expiry date is based on the average rate of deterioration of the drug product under standard conditions of temperature, humidity, and light. Moreover, deterioration of a drug product depends upon the form of the product and the manufacturing technique, the quality of the drug substance, excipients, and the storage conditions.
Some might argue that having expired drugs for treatment of diseases in a disaster setting is better than no drug treatment at all. The questions that come to mind with expired drugs are:
1. What is the potency of the active component of the drug in the product? That is, what is the percentage loss in the post-expiration date period: 10%, 20%, 30%, 40%, or 50%? 2. What is the likely effect of degraded drugs on the patient? 3. What is the effect of packaging and storage conditions on the stability of the drug product? Chemical and physical instability are some of the properties exhibited by pharmaceutical compounds. The rate of decomposition of formulated products may be first order, second order, or zero order, or by even more complex reactions. Temperature, hydrolysis, racemisation, oxidation, interaction between components within the product formulation, and photochemical decomposition are some of the factors that accelerate the rate of these reactions. 2 Although preservative antioxidants and stabilizing agents are added during the manufacturing process to retard such reactions, they do not ensure the stability of the product beyond the specified period. The container of a drug product may affect its stability. The plastic (polyvinyl) containers that are commonly used may affect the stability of the formulation. Leaching of alkali and production of decomposition flakes into the product may be caused by glass (the most inert material for containers). Such a modification of the original formulation may, in turn, initiate a chemical reaction.
Expiry dates of drug products are applicable only if specified storage requirements are satisfied. Temperate climatic conditions generally satisfy these requirements, but in tropical climates, where high humidity and high temperatures prevail, problems may arise. Both elevated temperature and high humidity can lead to increased rates of drug decomposition and, consequently, a reduction in the shelf lives of drug products. 3 York 3 performed accelerated storage tests to predict shelf lives of several commercial preparations of 2 brands of sulphathathiazole tablets, tetracycline hydrochloride capsules, and chloramphenicol capsules stored under temperate and tropical climatic conditions. These products were studied over 3 months. Shelf lives ranging from 6.2 to 29.7 months were predicted for temperate stor-age conditions (20˚C/31% relative humidity [RH]). These periods were reduced to 3.8-13.9 months for tropical conditions of 30˚C/31% RH and 2.5-9.2 months when stored at 30˚C/75% RH. A decrease in dissolution rate was also observed for products stored directly under conditions of elevated temperature and humidity.
York's findings indicated the need for stringent control over the storage of antibiotic preparations in tropical climates to ensure adequate drug stability and dissolution characteristics. The drugs studied exhibited poor aqueous solubility and, for drugs in this category, the dissolution process is often the rate-limiting step in absorption. 3 The consequence of poor dissolution for these drug products would, therefore, be poor absorption and probable therapeutic failure.
In tropical developing countries, heat waves are accompanied by a poor supply of electricity that disturbs the functioning of electrically operated appliances designed to maintain environmental temperatures at appropriate levels. 4 Arya 5 warned that the cumulative effect of high temperature, humidity, and poor air-cooling on potency of different therapeutic agents in the possession of travelers in the tropical parts of the world could be disastrous. He concluded that the potency of medications carried by travelers in these parts of the world could be similar to that of drugs taken by the native population. Assays of field samples of chloroquine, amoxicillin, tetracycline, trimethoprim/sulfamethoxazole (TMP/SMX), and ampicillin/cloxacillin in Nigeria and Thailand showed that 36.5% of the samples were substandard. 6 A 2-year study conducted in Burkina Faso prospectively evaluated the stability of 27 essential drugs, which ranged from antibiotics such as ampicillin and erythromycin to antiparasitics such as chloroquine and TMP/SMX to diuretics such as furosemide. 7 The drug products were stored at a rural site and an urban one where temperature and hygrometry were recorded daily. Quantitative analysis showed that the majority of samples suffered no significant loss of their active ingredient. In contrast, ampicillin, erythromycin, sulfaguanidine, injectable furosemide, penicillin G, TMP/SMX, and chloroquine showed >10% quantitative loss of their active ingredients. By the definition of chemical activity during a drug's shelf life, these drugs had lost their potency. Thus, the authors recommended that essential drugs should not be stored for more than one year in a tropical climate.
In a study of the effect of shipment on the stability of 11 essential drugs from UNICEF in Copenhagen, Denmark, to the tropics (by sea to Lagos, Nigeria, and Mombasa, Kenya, and by land to Kampala, Uganda, and Bangkok, Thailand), ampuls of ergometrine showed large variations in the amount of active ingredients after shipment. 8 In fact, 3 of 80 samples of ergometrine had concentrations <60% below those stated on the label. The investigators found that the drugs were exposed to much higher temperature and humidity levels than was recommended by the manufacturer, especially in tropical harbors and during inland transport. Except for ergometrine and methylergometrine, transportation did not affect the other drugs such as ampicillin, benzylpenicillin, phenomethylpenicillin, and tetracycline. Thus, it is not hard to imagine what the impact of unfavorable storage conditions might have on drugs expired or close to being expired shipped to tropical countries.
The consequence of treating patients with partially degraded drugs is probably a reduction in therapeutic response, which may be difficult to recognize or quantify. However, if degradation is significant, it can have serious consequences, such as use of inactive chloroquine or penicillin that would cause resistance or treatment failure. Degraded drugs have also been reported to cause harm. 9 Berckmans et al. 10 reported on the donation of drugs to Bosnia and Herzegovina from 1992 to 1996. The authors investigated rumors about massive quantities of irrelevant drugs that arrived in Mostar, Tuzla, Gorazde, Sarajevo, and Bihac, cities that were key targets for humanitarian assistance. The quality of the drugs was assessed according to their appropriateness or inappropriateness. Inappropriate drugs were defined as useless and unusable medicines. Unusable drugs were those that had already expired at the time of their arrival or soon afterward, unidentifiable drugs (ie, those delivered unsorted or labeled in unknown foreign languages), drugs damaged during shelling of warehouses, and those spoiled during transportation and storage. Drugs irrelevant to the epidemiology and clinical context or those not on the World Health Organization's (WHO's) essential drugs list were termed useless. 11 The authors estimated that 50 -60% of the 27 800 -34 800 metric tons of drugs and medical materials that entered Bosnia and Herzegovina between 1992 and mid-1996 were inappropriate. 10 Although miscellaneous donations of small amounts of drugs accounted for 60% of all inappropriate donations, they also documented dumping of large quantities, which accounted for 35% of such inappropriate donations.
Berckmans et al. 10 concluded, "our investigations nonetheless underscore that inappropriate medical donations to Bosnia and Herzegovina were common, as they were to Armenia 12 and Mexico 13 after their earthquakes, or to Africa during its food crisis, 14,15 and to the former Soviet Union. 16 Individuals and organizations have many reasons for sending medical supplies to a disaster area. Charitable gifts may lead to tax deductions and represent a convenient way to dispose of waste medical supplies without having to pay for their destruction. Publicity about humanitarian aid usually promotes the image of the people or organizations involved."
The nongovernmental organization (NGO) consortium (consisting of DIFÄM from Germany, ReMeD from France, Prosalus from Spain, and Wemos Foundation and co-funded by the European Commission, DGVII, the Dutch Ministry of Health and Netherlands Development Assistance of the Ministry of Foreign affairs), whose objective is to promote appropriate drug donations, reported that, during the Eritrean war for independence, inappropriate drugs were dumped on that nation. Despite careful wording of appeals, many inappropriate donations were received. "Examples were: 7 truck loads of expired aspirin tablets that took 6 months to burn, a whole container of unsolicited cardiovascular drugs with 2 months to expiry, and 30 000 half-liter bottles of expired amino acid infusion that could not be disposed of anywhere near a settlement because of the smell." 17 The cost of destroying unusable drugs adds to the health and environmental hazards, as well as the costs of storing, handling, sorting, and managing the useless and unusable drugs.
The Food and Drug Administration, in its Human Drug Current Good Manufacturing Practice Notes, created from 21 CFR 211.137(a) and (d), Expiration Dating, answers the question, "Is it acceptable for a firm to export expired drugs for charity?", as follows: "No. While we recognize the dire need for drugs in distressed parts of the world, once the expiration date has passed there is no assurance that the drugs have the safety, identity, strength, quality, and purity characteristics they purport or represent to possess. As such, expired drugs are adulterated within the meaning of section 501 (a)(2)(B) of the FD&C [Food, Drug, and Cosmetic] Act, and section 301 of the Act prohibits the introduction or delivery for introduction into interstate commerce any drug that is adulterated. 18, 19 Firms may wish to extend the labeled expiration date, thus making them suitable for export, provided that any extension of the expiration dating is supported by appropriate stability studies. Any extension of the expiration dating should be of sufficient duration to ensure that the drugs do not again reach their expiry before their anticipated use."
The "Guidelines for Drug Donations," produced by the WHO in cooperation with major international agencies active in humanitarian relief, stipulates that all donated drugs should be obtained from reliable sources and comply with quality standards in both the donor and recipient countries. 20 The guidelines also stipulate that the "WHO Certification Scheme on the Quality of Pharmaceutical Products Moving in International Commerce" should be used. 21 It further states, "This provision prevents double standards: drugs of unacceptable quality in the donor country should not be donated to other countries. Donated drugs should be authorized for sale in the country of origin, and manufactured in accordance with international standards of Good Manufacturing Practice (GMP)." Possible exceptions are: "In acute emergencies the use of the WHO Certification Scheme may not be practical. However, if it is not used, a justification should be given by the donor. When donors provide funds to purchase drugs from local producers, those which comply with national standards should not be excluded on the sole grounds that they do not meet quality standards of the donor country." Also, the Canadian Health Products and Food Branch Inspectorate, in an answer to a question on the acceptability of the donation of expired drugs to charity on their Web page, responded as follows: "No. While it is recognized [that there is a] dire need for drugs in distressed parts of the world, once the expiration date has passed there is no assurance that the drugs have the safety, identity, strength, quality and purity characteristics they purport or represent to possess. As such, expired drugs are adulterated which as such prohibits the introduction or delivery for introduction into commerce any drug that is adulterated." 22 Thus, it is clear that expired drugs are adulterated and are prohibited for export in the US, Canada, and the European Union, and unacceptable to the WHO and major charitable organizations that have teamed up to produce a guideline for drug donations to distressed nations. The guideline was produced in an effort to prevent the dumping of expired drugs on poor/distressed nations. In fact, the governments of these nations consider the introduction and circulation of expired drugs into their health systems illegal. 2, 23 In response to Berckmans et al.'s 10 research, one author defended the donation of expired drugs as being acceptable, since they may retain some biological activity. 24 Berckmans' group 25 reiterated the fact that contending the donation of expired drugs was acceptable was an open invitation to send drugs nearing their expiration date to any area in the world where humanitarian assistance seems necessary. They posed a question that is useful for us to ponder: "Why should a potential criminal act in one country be seen as virtuous when other populations are concerned?" Once the expiration date for a drug product has passed, the quality of the drug product cannot be guaranteed unless further tests are done to qualify the product and a new expiration date is set. This is what was done for tons of drugs used by the US military after they had expired. 26 That is, the drugs were subjected to stability testing, and new expiration dates were established before the drugs were released for use by the military.
Another question that needs to be answered is "Can you write a prescription for or fill one with an expired drug when you know that it is expired?" Can we donate expired drugs to any group of people in distress with a clear conscience toward God and man? The golden rule, do unto others as you wish them to do unto you, should apply here. Thus, the question of donating expired drugs to developing/distressed countries is a matter of conscience, and, by the standards of national and international laws and regulations, illegal. Compliance with the WHO and donor country standards and coordination with recipient countries could go a long way to minimize the donation of expired drugs to distressed nations.
